MetaVia Inc.
Organization details
- Legal name
- MetaVia Inc.
- Former names
- NeuroBo Pharmaceuticals, Inc. Gemphire Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Cambridge
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MTVA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001638287
- EIN
- 47-2389984
Board of directors
-
Andrew I. Koven · DirectorSince 2023
-
D. Gordon Strickland · DirectorSince 2023
-
Hyung Heon Kim · Director · CEO & PresidentSince 2023
-
James Patrick Tursi · DirectorSince 2023
-
Jason L. Groves · DirectorSince 2023
-
Mark A. Glickman · DirectorSince 2023
-
Michael Salsbury · DirectorSince 2023
-
Na Yeon Kim · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 8, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.6%
-
99.6%
Board connections
2 of this board's directors also sit on 2 other boards. 2 are in the same sector.
-
BioStem Technologies Inc. Same sectorvia Mark A. Glickman
-
KALA BIO Inc. Same sectorvia Andrew I. Koven
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 12, 2026 | Browne Sarah Kaplan Officer (Chief Medical Officer) | Grant or award | +53,000 | — | — |
| Jun 8, 2026 | James Patrick Tursi Director | Grant or award | +17,186 | — | — |
| Jun 8, 2026 | D. Gordon Strickland Director | Grant or award | +17,186 | — | — |
| Jun 8, 2026 | Michael Salsbury Director | Grant or award | +17,186 | — | — |
| Jun 8, 2026 | Jason L. Groves Director | Grant or award | +17,186 | — | — |
| Jun 8, 2026 | Andrew I. Koven Director | Grant or award | +17,186 | — | — |
| Jun 8, 2026 | Mark A. Glickman Director | Grant or award | +17,186 | — | — |
| Jan 23, 2026 | Woodworth Marshall H Officer (Chief Financial Officer) | Grant or award | +28,000 | — | — |
| Jan 23, 2026 | Hyung Heon Kim Director, Officer (CEO & President) | Grant or award | +32,000 | — | — |
| Aug 12, 2025 | Woodworth Marshall H Officer (Chief Financial Officer) | Gift | −14,200 | — | — |
| Jun 30, 2025 | Mark A. Glickman Director | Grant or award | +28,147 | — | — |
| Jun 30, 2025 | Jason L. Groves Director | Grant or award | +28,147 | — | — |
| Jun 30, 2025 | James Patrick Tursi Director | Grant or award | +28,147 | — | — |
| Jun 30, 2025 | D. Gordon Strickland Director | Grant or award | +28,147 | — | — |
| Jun 30, 2025 | Andrew I. Koven Director | Grant or award | +28,147 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about MetaVia Inc.
Who is the CEO of MetaVia Inc.?
Hyung Heon Kim is MetaVia Inc.'s CEO & President.
How many directors are on MetaVia Inc.'s board?
MetaVia Inc.'s board has 8 directors: Andrew I. Koven, D. Gordon Strickland, Hyung Heon Kim, James Patrick Tursi, Jason L. Groves, Mark A. Glickman, Michael Salsbury and Na Yeon Kim.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="metavia-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.